Galmed Pharmaceuticals Ltd (NASDAQ:GLMD)

6.18
Delayed Data
As of Apr 20
 -0.09 / -1.44%
Today’s Change
3.61
Today|||52-Week Range
12.22
-32.46%
Year-to-Date
No recent news for Galmed Pharmaceuticals Ltd.

Today’s Trading

Previous close6.27
Today’s open6.09
Day’s range6.02 - 6.21
Volume8,933
Average volume (3 months)85,838
Market cap$96.3M
Data as of 3:51pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)-55.21%
Earnings growth (this year)+36.51%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales85.49
Price/Book7.00

Competitors

 Today’s
change
Today’s
% change
RGLSRegulus Therapeutics...-0.01-0.94%
GTXIGTX Inc+0.42+2.51%
MEIPMEI Pharma Inc-0.02-0.92%
ZFGNZafgen Inc-0.01-0.15%
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateMay 14, 2018
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$467.0K
Annual profit (last year)-$17.0M
Net profit margin-3,630.19%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Allen Baharaff
Chief Financial Officer
Yohai Stenzler
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts